This report examines the models of recreational cannabis legalisation that are currently being implemented in Europe, their nuances, and the commercial opportunities they may provide
Join Tamarind Intelligence founder Tim Phillips and Editorial Director Barnaby Page as they explore the complexities of the illicit e-cigarette trade.
Brazilian pharmaceutical company Ease Labs officially announced the acquisition this month of Plena, a cannabis cultivation and extraction company based in Colombia
Clinical trials on CBD-based medical drug Epidiolex missed their main goal of registering a significant reduction in the frequency of seizures experienced by patients in Japan, based on the results reported by manufacturer Jazz Pharmaceuticals
Republican nominee for vice-president JD Vance has been silent on vaping, tobacco alternatives and the Ohio cannabis legalisation debate, but some of his comments suggest he may support the regulation of recreational cannabis
Executives were taken aback by the enthusiasm vendors showed for a nicotine vape brand in Dubai with a US West Coast theme, even though it involves a product that the UAE only recently legalised
The proposed and withdrawn amendment to ban CBD products in Italy has reappeared as part of a bill aimed at enhancing public safety and combating crime
CannIntelligence presents the latest regulatory and market developments and trends in the global cannabis industry in slide deck format. The slide deck covers the latest developments from the second quarter of 2024
Though debate about US president Joe Biden’s potential replacement dominates headlines on the November elections, down-ballot races in many states may impact the future of cannabis in the country
This report examines products offered online in the US that contain alternative active ingredients, such as intoxicating hemp-derived cannabinoids (IHDCs), kratom and mushrooms
The Europe HHC regulatory tracker offers an in-depth analysis of the regulations surrounding hexahydrocannabinol (HHC) in 30 European countries
HHC is likely to become illegal very soon in Germany, as the country’s Federal Council prepares to pass a government decree on the subject on 14th June